3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Anterior Choroidal Artery Infarction in 1 studies
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, LL | 1 |
| Lee, GE | 1 |
| Lee, TB | 1 |
| Rush, DK | 1 |
| Wilmot, CA | 1 |
| Paulus, E | 1 |
| Elben, U | 1 |
| Grome, JJ | 1 |
| Porsche-Wiebking, E | 1 |
| Rudolphi, KA | 1 |
1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Synthesis, resolution, and SAR of (+/-)-2-amino-N-methyl-alpha-(3-methyl-2-thienyl)benzeneethanamine++ + and related analogs as noncompetitive NMDA antagonists with neuroprotective properties.
Topics: Aniline Compounds; Animals; Anti-Anxiety Agents; Anticonvulsants; Binding, Competitive; Brain Ischem | 1994 |